There is significant interest in the correlation between adipose regulators of metabolism, inflammation, and the occurrence of osteoarthritis (OA). In this issue of Arthritis & Rheumatism, Griffin and colleagues report the results of their investigation of the role of leptin (1). The investigators hypothesized that obesity in mice resulting from deletion of the leptin gene (ob/ob) or deletion of the leptin receptor gene (db/db) would result in an increased incidence of knee OA, systemic inflammation, and altered subchondral bone morphology. In both of these mouse strains, adiposity was increased by ϳ10-fold compared with controls. Surprisingly, the incidence of OA was not higher in ob/ob and db/db mice than in the control background strain, C57BL/6J mice.These results suggest that obesity alone does not cause OA. However, other changes occurred in these mice due to the loss of leptin function. Leptin-deficient mice had reduced subchondral bone thickness and increased relative trabecular bone volume in the tibial epiphysis, as previously reported (for review, see ref.2). An extensive analysis of inflammatory molecules was carried out by Luminex bead assay, which revealed an increased level of only interleukin-8 (IL-8) and thus not an overall inflammatory effect of leptin deficiency. These results imply that leptin may be involved in the development of OA. Without leptin, adiposity is insufficient to induce systemic inflammation and knee OA, suggesting a potential role of leptin itself in regulating skeletal and immune functions.